Survival for three years after intramyocardial high malignant non-Hodgkin lymphoma.
Yates
A
A
Department of Surgery, Division of Cardiac Surgery, University of Graz, Austria. ameli.yates@uni-graz.at
Huber
S
S
Unger
B
B
Rigler
B
B
D000208:Acute Disease; D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D002303:Cardiac Output, Low / Q000209:etiology* / Q000601:surgery; D003131:Combined Modality Therapy; D005260:Female; D006338:Heart Neoplasms / Q000188:drug therapy / Q000601:surgery*; D006801:Humans; D007108:Immune Tolerance; D016393:Lymphoma, B-Cell / Q000188:drug therapy / Q000601:surgery*; D017741:Survivors; D014694:Ventricular Outflow Obstruction / Q000209:etiology
D000903:Antibiotics, Antineoplastic